Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Journal:
Current Gene Therapy
Volume:
4
Page:
41-51
Author(s):
Dawn E. Post, Giulia Fulci, E. Antonio Chiocca and Erwin G. Van Meir
Potential of Gene Therapy for the Treatment of Pituitary Tumors
Journal:
Current Gene Therapy
Volume:
4
Page:
79-87
Author(s):
R. G. Goya, D. K. Sarkar, O. A. Brown and C. B. Herenu
Subject Index to Volume 3
Journal:
Current Gene Therapy
Volume:
4
Page:
139-143
Author(s):
Bentham Science Publishers
The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
111-124
Author(s):
Patrick Onyango
Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
125-146
Author(s):
Johann Hofmann
Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
147-163
Author(s):
Albert F. Kabore, James B. Johnston and Spencer B. Gibson
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Journal:
Current Pharmacogenomics
Volume:
2
Page:
75-82
Author(s):
R. M. Phillips and S. Basu
Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
123-138
Author(s):
Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni
Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
27-34
Author(s):
Ken-ichi Tanaka and Norio Ogawa
Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
647-657
Author(s):
A. Sorokin